Recurrent Implantation Failure (RIF) Completed Phase 2 Trials for Sirolimus (DB00877)

Also known as: Recurrent Implantation Failure

IndicationStatusPhase
DBCOND0078432 (Recurrent Implantation Failure (RIF))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03161340Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation FailureTreatment